Known targets — ChEMBL curated mechanism
GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ
The experimentally established mechanism targets of Flunitrazepam. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 known ✓ | P14867 | 10/20 | 1.00 |
| ▸ | GABRA5 known ✓ | P31644 | 10/20 | 1.00 |
| ▸ | GABRA3 known ✓ | P34903 | 9/20 | 1.00 |
| ▸ | GABRA2 known ✓ | P47869 | 9/20 | 1.00 |
| ▸ | GABRG2 known ✓ | P18507 | 8/20 | 1.00 |
| ▸ | GABRB3 known ✓ | P28472 | 8/20 | 1.00 |
| ▸ | GABRB2 known ✓ | P47870 | 7/20 | 1.00 |
| ▸ | GABRP known ✓ | O00591 | 1/20 | 0.48 |
| ▸ | GABRD known ✓ | O14764 | 1/20 | 0.48 |
| ▸ | GABRB1 known ✓ | P18505 | 1/20 | 0.48 |
| ▸ | GABRA4 known ✓ | P48169 | 1/20 | 0.48 |
| ▸ | GABRE known ✓ | P78334 | 1/20 | 0.48 |
| ▸ | GABRA6 known ✓ | Q16445 | 1/20 | 0.48 |
| ▸ | GABRG1 known ✓ | Q8N1C3 | 1/20 | 0.48 |
| ▸ | GABRG3 known ✓ | Q99928 | 1/20 | 0.48 |
| ▸ | GABRQ known ✓ | Q9UN88 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 3/20 | 1.00 |
| ▸ | GHSR | Q92847 | 2/20 | 1.00 |
| ▸ | CCKBR | P32239 | 2/20 | 1.00 |
| ▸ | MC3R | P41968 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flunitrazepam SCHEMBL16922172 | 1.00 | GABRA1 (1.00) | GABRA1GABRA5GABRA3GABRA2GABRG2 | |
| Flunitrazepam SCHEMBL29902314 | 1.00 | GABRA1 (1.00) | GABRA1GABRA5GABRA3GABRA2GABRG2 | |
| Flunitrazepam SCHEMBL29372584 | 1.00 | GABRA1 (1.00) | GABRA1GABRA5GABRA3GABRA2GABRG2 | |
| Flunitrazepam SCHEMBL8812488 | 1.00 | GABRA1 (1.00) | GABRA1GABRA5GABRA3GABRA2GABRG2 | |
| Flunitrazepam SCHEMBL27607836 | 0.95 | GABRA1 (0.90) | GABRA1GABRA5GABRA3GABRA2GABRG2 | |
| Flunitrazepam SCHEMBL6703617 | 0.95 | GABRA1 (0.90) | GABRA1GABRA5GABRA3GABRA2GABRG2 | |
| Flunitrazepam SCHEMBL11140334 | 0.92 | GABRA1 (0.85) | GABRA1GABRA5GABRA3GABRA2GABRG2 | |
| Flunitrazepam SCHEMBL1900353 | 0.90 | GABRA1 (0.80) | GABRA1GABRA5GABRA3GABRA2GABRG2 | |
| SCHEMBL2615311 | 0.87 | GABRA1 (0.77) | GABRA1GABRA5GABRA3GABRA2GABRG2 | |
| SCHEMBL9473650 | 0.87 | GABRA1 (0.78) | GABRA1GABRA5GABRA3GABRA2GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 12184 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624036-B2 | Method of treating post-traumatic stress disorder | INTRA-CELLULAR THERAPIES, INC. (US) | 2026-05-12 | — | — | US | claimed |
| US-12624037-B2 | Method of treating agitation, aggressive behavior, and impulse control disorder | INTRA-CELLULAR THERAPIES, INC. (US) | 2026-05-12 | — | — | US | claimed |
| EP-4719552-A1 | INDUCTION OF GENERAL ANESTHESIA IN ADULTS UNDERGOING ELECTIVE SURGERY | Xizang Haisco Pharmaceutical Co., Ltd. (CN) | 2026-04-08 | — | — | EP | claimed |
| US-20260076953-A1 | METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2026-03-19 | — | — | US | claimed |
| EP-3507371-B1 | COMPOSITIONS FOR TREATING DISEASES AND DISORDERS OF THE NERVOUS SYSTEM | UNIV RUTGERS (US) | 2026-01-28 | — | — | EP | claimed |
| US-12525764-B2 | Devices for generation of electromagnetic radiation of predetermined profile | Terahertz Group Ltd. (IL) | 2026-01-13 | — | — | US | claimed |
| US-12498358-B2 | Bracelet to test for knock-out drops | TWINVAY GMBH (DE) | 2025-12-16 | — | — | US | claimed |
| US-20250375421-A1 | METHODS OF USING DMT | SHULMAN WILLIAM (US) | 2025-12-11 | — | — | US | claimed |
| US-20250368929-A1 | PACK FOR POTENTIALLY HARMFUL SUBSTANCES REMOVAL AND METHOD OF USE | ALKAA IND LLC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250295671-A1 | Hazardous Agent Injection System | ANTARES PHARMA, INC. (US) | 2025-09-25 | — | — | US | claimed |
| EP-0150721-A2 | Drug | Firma Paliz, Ziegler (CH) | 1985-08-07 | — | — | EP | claimed |
| EP-0050487-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A BENZODIAZEPINE DRUG AND A PHENANTHRIDINE DERIVATIVE | PFIZER INC. (US) | 1984-09-26 | — | — | EP | claimed |
| US-4411894-A | Pharmaceutical preparations | HOFFMANN-LA ROCHE INC. (US) | 1983-10-25 | — | — | US | claimed |
| US-4316897-A | TRANQUILIZERS | HOFFMANN-LA ROCHE INC. (US) | 1982-02-23 | — | — | US | claimed |
| US-4280993-A | TRITIUM -RADIOACTIVE LABELED BENZODIAZEPINES BONDED TO BRAIN TISSUES | A/S FERROSAN (DK) | 1981-07-28 | — | — | US | claimed |
| EP-0025546-A2 | Therapeutical use of tranquillizing benzodiazepine derivatives and mixtures containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-03-25 | — | — | EP | claimed |
| EP-0022771-A4 | RADIO RECEPTOR ASSAY FOR BENZODIAZEPINES IN PLASMA AND OTHER BIOLOGICAL SPECIMENS. | US HEALTH (US) | 1981-02-04 | — | — | EP | claimed |
| EP-0022771-A1 | RADIO RECEPTOR ASSAY FOR BENZODIAZEPINES IN PLASMA AND OTHER BIOLOGICAL SPECIMENS | THE UNITED STATES OF AMERICA, represented by DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1981-01-28 | — | — | EP | claimed |
| US-4239744-A | DIAGNOSIS OF DRUG OVERDOSE | UNITED STATES OF AMERICA (US) | 1980-12-16 | — | — | US | claimed |
| WO-1980000750-A1 | RADIO RECEPTOR ASSAY FOR BENZODIZAPINES IN PLASMA AND OTHER BIOLOGICAL SPECIMENS | US COMMERCE (US) | 1980-04-17 | — | — | WO | claimed |